TransMedics Group amended its 2019 Stock Incentive Plan to increase the share reserve to 5.39 million shares and extend the plan term to June 1, 2036, while implementing a one-year minimum vesting requirement for awards granted after January 1, 2027. The amendments reflect the company's ongoing equity compensation strategy and shareholder approval of enhanced incentive plan provisions.